Table 1.
Crude and corrected estimations of Simian Immunodeficiency Virus (SIV) infection rate in wild chimpanzees from different field sites in Gabon (2009–2013).
| HIV Antibody Positive Profile | HIV Antibody Negative Profile | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collection Sites | Faecal Samples Collected | SIVcpz Antibody Positive Samples | Estimated Number Of Individuals Collected | Samples Successfully Genotyped/not Genotyped | Prevalence Of SIVcpz Antibody Positive (%) Genotyped Animals (Individuals) | vRNA Positive Genotyped Animals pol / envA | SIVcpz Antibody Positive Samples | Number Of vRNA Positive Samples pol / envB | Antibody Negative Samples Tested By PCR | Number Of Individuals Tested By PCR | Number Of vRNA Positive Individuals pol / envC | Samples Tested By PCR | Number Of vRNA Positive Samples pol / envD |
| LP | 54 | 0 | |||||||||||
| MI | 194 | 0 | |||||||||||
| TS | 13 | 0 | |||||||||||
| MK | 11 | 0 | |||||||||||
| LA | 16 | 0 | |||||||||||
| MA | 608 | 263 (44%) | 224 | 504/104 | 103 (46%) | 23/18 | 44 | 6/4 | 146 | 50 | 5/6 | 23 | 2/1 |
| MC | 33 | 0 | |||||||||||
| IV | 19 | 0 | |||||||||||
| DJ | 40 | 8 (20%) | |||||||||||
| ML | 181 | 85 (47%) | 19 | 85/96 | 12 (63.5%) | 5/1 | 47 | 5/2 | |||||
| WA | 18 | 0 | |||||||||||
| LN | 12 | 0 | |||||||||||
| OY | 78 | 1 (1.3%) | |||||||||||
| IY | 31 | 18 (58%) | 12 | 25/6 | 4 (33.3%) | 1 / 0 | |||||||
| OD | 39 | 5 (12.8%) | 17 | 35/4 | 4 (23.5%) | 0 | |||||||
| LO | 111 | 0 | |||||||||||
| Total | 1458 | 380 (26,1) | 272 | 649/210 | 123 (41.6%) | 29/19 | 91 | 11/6 | 146 | 50 | 5/6 | 23 | 2/1 |
A In MA and ML sites 11 and 1 SIV strains were both amplified in pol and env respectively. B In MA and ML site 2 and 2 SIV strains were both amplified in pol and env respectively. C 5 SIV strains were both amplified in pol and env. D 1 strains were both amplified in pol and env.